"Drug Packaging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.
| Descriptor ID |
D004349
|
| MeSH Number(s) |
E05.916.320 J01.576.655.750.321 J01.576.761.300
|
| Concept/Terms |
Drug Packaging- Drug Packaging
- Packaging, Drug
- Drug Packagings
- Packagings, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Packaging".
Below are MeSH descriptors whose meaning is more specific than "Drug Packaging".
This graph shows the total number of publications written about "Drug Packaging" by people in this website by year, and whether "Drug Packaging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Packaging" by people in Profiles.
-
Komm C, Rochani A, Fox T, Kaushal G. Stability of extemporaneously compounded 5-fluorouracil utilizing high performance liquid chromatography. Drug Discov Ther. 2022; 16(1):1-7.
-
Hinkle JW, Hsu J. THE RELATIONSHIP BETWEEN STOPPER POSITION AND INJECTION VOLUME IN RANIBIZUMAB AND AFLIBERCEPT PREFILLED SYRINGES. Retina. 2021 Dec 01; 41(12):2510-2514.
-
Vaughn SR, Radwick A. How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems. Int J Pharm Compd. 2020 Jan-Feb; 24(1):14-19.
-
Storey PP, Ho V, Yeh S, Reddy S, Fang-Yen NH, Pequignot E, Leiby BE, Fineman M, Garg S, Hubbard GB, Hsu J. INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2015 Oct; 35(10):1992-2000.
-
Yannuzzi NA, Klufas MA, Quach L, Beatty LM, Kaminsky SM, Crystal RG, D'Amico DJ, Kiss S. Evaluation of compounded bevacizumab prepared for intravitreal injection. JAMA Ophthalmol. 2015 Jan; 133(1):32-9.
-
Kaushal G, Sayre BE, Prettyman T. Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags. Am J Health Syst Pharm. 2013 May 15; 70(10):894-9.
-
Zmistowski B, Austin L, Ciccotti M, Ricchetti E, Williams G. Fatal venous air embolism during shoulder arthroscopy: a case report. J Bone Joint Surg Am. 2010 Sep 01; 92(11):2125-7.
-
Austin L, Zmistowski B, Tucker B, Hetrick R, Curry P, Williams G. Commercial liquid bags as a potential source of venous air embolism in shoulder arthroscopy. J Bone Joint Surg Am. 2010 Sep 01; 92(11):2110-4.
-
Roth JV. How to enter a medication vial without coring. Anesth Analg. 2007 Jun; 104(6):1615.
-
Krueger KP, Felkey BG, Berger BA. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc (2003). 2003 Nov-Dec; 43(6):668-78; quiz 678-9.